MAMMOMAT B.brilliant

by SIEMENS MEDICAL SOLUTIONS USA  · Based in United States →Women deserve clarity.
General Surgery Oncology Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

The MAMMOMAT B.brilliant is Siemens Healthineers’ first completely redesigned mammography platform in over a decade, engineered to advance breast imaging with a focus on accuracy, speed, and patient comfort. This innovative system integrates new 3D image acquisition and reconstruction technology, offering capabilities for full-field digital mammography (2D), breast biopsy, and advanced titanium contrast-enhanced mammography (CEM).

A key feature is its 50-degree wide-angle tomosynthesis, powered by PlatinumTomo 3D technology, which enables high-resolution 3D breast images to be acquired in under five seconds. This wide angle provides superior tissue separation, helping radiologists visualize otherwise obscured lesions and microcalcifications more clearly. The system incorporates a new detector and an X-ray tube with flying focal-spot technology, adapted from Siemens’ CT scanners, to enhance the visualization of microcalcifications.

UltraHD image reconstruction technology further refines image quality by reducing metal artifacts, providing crisp visualization of calcifications, and offering customizable image settings. It also generates a synthetic 2D image without additional radiation exposure to the patient. For contrast-enhanced examinations, the newly developed ClearCEM image reconstruction technique delivers crystal-clear enhancement and consistent image quality, particularly beneficial for lesion detection in dense breast tissue. The system also supports ClearCEM Biopsy, increasing diagnostic confidence without the need to switch imaging modalities.

Patient comfort is significantly improved through features such as personalized soft breast compression, an ergonomic hand grip, and an optimized stationary face shield. Technologist workflow and ergonomics are enhanced by features like ComfortMove, which allows automated and independent movement of the tube head, and a prominent display monitor for clear visibility of patient information and work steps. For biopsies, a needle navigator provides visual feedback for precise targeting, and InSpect integrates specimen imaging for quick review. Designed as an on-site solution, MAMMOMAT B.brilliant aims for cost-effectiveness and high availability in radiology practices.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • 50u00b0 Wide-Angle Tomosynthesis (PlatinumTomo 3D)
  • Under 5-second 3D image acquisition
  • UltraHD PREMIA Image Reconstruction (AI-enabled denoising, customizable settings)
  • Flying Focal Spot Technology for microcalcification visualization
  • ClearCEM (Titanium Contrast-Enhanced Mammography)
  • ClearCEM Biopsy with wide-angle tomosynthesis guidance
  • Synthetic 2D images (no additional radiation)
  • Intelligent Personalized Compression
  • ComfortMove (automated ergonomic tube head movement)
  • ComfortPackage (ergonomic hand grip, optimized face shield)
  • Needle Navigator for biopsy targeting
  • InSpect integrated specimen imaging

Use Cases

  • Breast cancer screening
  • Diagnostic clarification of suspicious findings
  • Imaging in dense breast tissue
  • Contrast-enhanced mammography (CEM)
  • 3D-guided breast biopsies
  • Visualization of microcalcifications

What Physicians Need to Know

Key Capabilities
Features PlatinumTomo 3D technology with 50u00b0 wide-angle tomosynthesis for high depth resolution and fast acquisition (under 5 seconds). Includes UltraHD PREMIA AI reconstruction for enhanced image quality, denoising, artifact reduction, and improved visibility of pathologies like calcifications and lesions. Supports full-field digital mammography (2D), breast biopsy (2D, 3D guided, stereo, contrast-enhanced), and Titanium Contrast-Enhanced Mammography (TiCEM) with a unique titanium filter for unlimited consecutive exams. Generates synthetic 2D images without additional radiation.
Clinical Utility
Aids in earlier and more reliable breast cancer detection by addressing overlapping tissue challenges and enhancing visualization of lesions and microcalcifications. Improves diagnostic confidence, especially in dense breast tissue, and can reduce false positives, false negatives, and the need for additional imaging or unnecessary biopsies. Offers a faster time-to-diagnosis and serves as a potential alternative to MRI for contrast-enhanced imaging.
Integration Options
Designed for seamless integration into existing imaging fleets and workflows, likely supporting standard DICOM connectivity for PACS and RIS. The system's advanced image reconstruction and visualization capabilities are intended to enhance the diagnostic reading experience within established hospital IT infrastructures.
Compliance Status
Received FDA 510(k) clearance for 2D mammography, breast biopsy, and titanium contrast-enhanced mammography in April 2024. The 3D (tomosynthesis) portion received FDA Premarket Approval (PMA) in September 2024. The 3D portion was commercially available in Europe, Asia, and South America prior to US FDA PMA. The ClearCEM image reconstruction technique for contrast-enhanced examinations is pending 510(k) clearance in the USA as of November 2025.
Pricing Model
Specific pricing details are not publicly disclosed, as is typical for capital medical equipment. However, it is designed for cost-effectiveness and high availability, aiming to maximize long-term potential for radiology practices and offering a low total cost of ownership.
User Experience
Prioritizes patient comfort with features like ambient lighting, personalized soft breast compression, curved paddles, an ergonomic hand grip, and a stationary face shield. Enhances technologist ergonomics and workflow with a prominent display, ComfortMove for independent tube head movement, a laser positioning guide, and smart automation tools like TomoFlow and One-Click Workflow. Recognized with a UX Design Award for its user-centered approach.
Support Quality
As a product from Siemens Healthineers, a global provider of healthcare equipment, solutions, and services, comprehensive support is implied through their established global presence and service network.
Evidence Base
Supported by a white paper on its fast, high-resolution wide-angle digital breast tomosynthesis. Studies indicate it shifts in-plane resolution of DBT into the high-resolution range of FFDM. Clinical testing of the ClearCEM technique showed exceptional image quality, even in dense breast tissue. General AI in breast imaging has shown potential to increase cancer detection rates by up to 29% and decrease false positives by 32%.
Physician Tip

Leverage the MAMMOMAT B.brilliant's 50u00b0 wide-angle tomosynthesis and AI-powered UltraHD PREMIA reconstruction for superior visualization of lesions and microcalcifications, especially beneficial in dense breast tissue. Utilize Titanium Contrast-Enhanced Mammography (TiCEM) for diagnostic clarification and as a potential MRI alternative, taking advantage of its unique filter for unlimited consecutive exams. The system's ergonomic design for both patients and technologists can enhance patient compliance and improve staff efficiency. Be mindful of the pending FDA clearance for the ClearCEM reconstruction technique if planning to use the most advanced contrast-enhanced features in the US.

The MAMMOMAT B.brilliant is engineered for seamless integration into existing imaging ecosystems, supporting standard DICOM protocols for efficient communication with Picture Archiving and Communication Systems (PACS) and Radiology Information Systems (RIS). Its advanced image reconstruction and visualization tools, such as synthetic 2D images and UltraHD PREMIA, are designed to enhance the diagnostic reading experience within established clinical workflows.

Details

Category Oncology AI, Radiology & Imaging AI
Pricing Contact for pricing
DeploymentOn-site solution
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The MAMMOMAT B.brilliant received initial FDA 510(k) clearance in April 2024 for full-field digital mammography, breast biopsy, and titanium contrast-enhanced mammography. It subsequently received Premarket Approval (PMA) P140011/S008 in September 2024 for its 3D tomosynthesis option, including PlatinumTomo and UltraHD reconstruction technology.

Integrations
EHR Not specified
Specialties General Surgery, Oncology, Radiology

What the Web Says

The Siemens Healthineers MAMMOMAT B.brilliant is a mammography system that has received positive feedback from physicians and healthcare professionals for its advanced imaging capabilities, patient-centric design, and improved workflow. It features wide-angle tomosynthesis, which provides high-resolution 3D images and enhanced visibility of microcalcifications, and also offers contrast-enhanced mammography (CEM) and biopsy capabilities. The system aims to improve diagnostic confidence, enhance the patient experience, and streamline operational efficiency in breast imaging.

Overall: Positive

Strengths

  • Excellent image quality for 2D FFDM and DBT, with enhanced visibility of microcalcifications and reduced metal artifacts.
  • Fast acquisition and reconstruction times for DBT, with 3D images acquired in under five seconds.
  • Improved patient comfort through features like mood lighting, curved SoftComp paddles, and an optimized face shield that allows patients to lean in.
  • Enhanced user ergonomics and workflow efficiency for technologists with features like ComfortMove, eye-level displays, and one-touch controls.
  • Modular and future-ready platform, allowing for upgrades and seamless integration of traditional 2D mammography and advanced 3D tomosynthesis.
  • FDA approved for 3D imaging, breast biopsy, and titanium contrast-enhanced mammography (TiCEM).

Limitations

  • More intense training required to become familiar with all new features and limitations compared to older systems.
  • Initial usability of controls was rated as not as intuitive as previous models, requiring additional button presses in certain situations (though this is understood to be resolved in a subsequent software update).
  • The InSpect (integrated specimen scanner) was not evaluated in one report, indicating it might not be a standard or fully integrated feature in all setups.
  • Some features like PRIME, Contrast-enhanced mammography, InSpect, or DBT in 'Perspective' mode were not part of the main evaluation in one report, suggesting potential limitations in the scope of initial practical assessments.
  • Higher initial investment cost compared to traditional film-based systems, which can be a financial challenge for some healthcare facilities.
  • No specific negative reviews from Reddit, G2, or Capterra were found in the search results.

Based on reviews from: Medical Physics, Siemens Healthineers, Frost & Sullivan, Cassling, Becker's Hospital Review, MedTech Dive, ICE Magazine, AuntMinnieEurope, Formacion Senologia, Precedence Research, Zenodo, Scribd, Toronto Breast Imaging Conference, OAMRS Spring 2025 Multidisciplinary Breast Imaging Symposium

Last updated: 2026-07-20

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate MAMMOMAT B.brilliant

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Applied Radiology
Siemens Healthineers' Mammomat B.brilliant Gains FDA Clearance for Enhanced Imaging and Biopsy | Applied Radiology
Siemens Healthineers' Mammomat B.brilliant mammography system received FDA clearance for new contrast-enhanced mammography (CEM) and CEM-guided biopsy capabilities, enhancing diagnostic precision, especially in dense breast tissue.
2026-06
Siemens Healthineers USA
Siemens Healthineers Receives FDA Clearance for Mammomat B.brilliant Contrast-Enhanced Mammography, Biopsy
Siemens Healthineers announced FDA clearance for new contrast-enhanced mammography (CEM) and CEM biopsy capabilities for its Mammomat B.brilliant system, featuring an improved image reconstruction technique for clearer diagnosis in dense breast tissue.
2026-06
AuntMinnieEurope
UPC orders Siemens to withdraw mammography systems | AuntMinnieEurope
Europe's Unified Patent Court (UPC) ordered Siemens Healthineers to recall its Mammomat B.brilliant breast tomosynthesis system from Germany, France, and the Netherlands due to a patent infringement ruling in favor of Hologic.
2026-06
Siemens Healthineers
Siemens Healthineers presents mammography system with groundbreaking new imaging technology, MAMMOMAT B.brilliant, in Canada
Siemens Healthineers announced that its MAMMOMAT B.brilliant, a redesigned mammography platform with wide-angle tomosynthesis, has received Health Canada licensing, offering advancements in image quality, user ergonomics, and patient comfort.
2024-06
Siemens Healthineers
Siemens Healthineers Expands Contrast-Enhanced Mammography and Biopsy Capabilities of MAMMOMAT B.brilliant
Siemens Healthineers introduced new capabilities for MAMMOMAT B.brilliant at RSNA 2025, advancing contrast-enhanced mammography and biopsy functionality with a newly developed image-reconstruction technique for clearer examinations.
2025-12
AuntMinnie
Siemens Healthineers gets FDA nod for Mammomat B.brilliant system - AuntMinnie
Siemens Healthineers' Mammomat B.brilliant mammography system received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for full-field digital mammography, 2D breast imaging, breast biopsy, and titanium contrast-enhanced mammography.
2024-04
MedTech Dive
Siemens Healthineers wins FDA approval for 3D mammography system | MedTech Dive
Siemens Healthineers received premarket approval for the 3D portion of its Mammomat B.brilliant platform, featuring new 3D image acquisition and reconstruction technology with a 50-degree wide-angle.
2024-10
PubMed Central (PMC)
Digital breast tomosynthesis system concept addressing the needs in breast cancer screening and diagnosis - PMC
This peer-reviewed article discusses the MAMMOMAT B.brilliant as a novel system concept developed to replace FFDM with DBT plus synthetic mammography in breast cancer screening, retaining wide-angle DBT benefits and achieving short acquisition times.
2024-12

Videos

Product demos, reviews, and walkthroughs for MAMMOMAT B.brilliant.

View all on YouTube

Frequently Asked Questions

The MAMMOMAT B.brilliant incorporates AI-enabled image denoising and UltraHD PREMIA image reconstruction to enhance image quality and adaptable image impressions. This AI technology supports radiologists by improving diagnostic accuracy, potentially reducing reading workload, and accelerating diagnostic processes through rapid image acquisition.
The MAMMOMAT B.brilliant system has received FDA 510(k) clearance for its 2D breast imaging, breast biopsy, and titanium contrast-enhanced mammography features. The 3D tomosynthesis portion, which includes new acquisition and reconstruction technology like PlatinumTomo and Premia AI reconstruction, has also received FDA Premarket Approval (PMA).
Other prominent AI mammography systems include Hologic Genius AI, GE Healthcare MyBreastAI, Fujifilm Transpara AI, and iCAD ProFound AI. The MAMMOMAT B.brilliant distinguishes itself with its 50u00b0 wide-angle tomosynthesis, which is designed to be the fastest wide-angle tomosynthesis system available, acquiring 3D images in approximately five seconds, and offering high depth resolution.
While pricing can vary significantly based on region, configuration, and additional features, one listing for a Digital Siemens MAMMOMAT B.brilliant Mammography Machine in New Delhi, India, indicated a price of approximately u20b94,050,000. It is advisable to contact Siemens Healthineers directly for specific pricing relevant to your location and needs.
While AI in MAMMOMAT B.brilliant enhances diagnostic accuracy and workflow, it is intended as a supplementary tool to assist radiologists, not to replace their expertise. Concerns exist regarding the potential for AI to miss subtle cancers, the need for ongoing research to confirm long-term benefits, and the importance of patient transparency and consent regarding AI's role in their imaging interpretation.

Related Tools

FAITH project (Fatigue Therapy – AI-supported Diagnosis and Therapy of Tumour-associated Fatigue Syndrome)
Fimo Health GmbH (Consortium Leader)
Mental & Behavioral Health AI
The FAITH project is developing an AI-based solution for the diagnosis and therapy of tumor-associated fatigue syndrome in cancer patients. It uses wearable sensors, a smartphone app, and artificial intelligence to provide individualized therapy recommendations and monitor mental health.
AI-based support system for skin cancer diagnostics
German Cancer Research Center (DKFZ)
Clinical Decision Support & Reference
Scientists at the German Cancer Research Center have developed an AI-based support system for skin cancer diagnostics that explains its decisions, increasing doctors' confidence in both the AI and their own diagnoses.
eyonis® LCS
Median Technologies
Oncology AI
eyonis® LCS is an FDA 510(k) cleared AI/machine learning-powered software for the detection and diagnosis of lung cancer, helping clinicians detect and characterize suspicious parenchymal pulmonary nodules earlier on low-dose CT scans.
Lumea Digital Pathology
Lumea
Clinical Decision Support & Reference
Lumea is a specialty-specific digital pathology platform that covers the entire diagnostic workflow, from biopsy to final report, and integrates AI tools from partners like Paige and Mindpeak.
Azra AI
Azra AI
Clinical Decision Support & Reference
Azra AI is an AI platform that swiftly analyzes, identifies, and classifies cancer patients, triaging those needing therapy and follow-up to enhance oncology care. It is deployed at more than 1,500 sites and integrated with leading EHRs.
Trial Library
Trial Library
Drug Discovery & Research
Trial Library's AI-native platform is embedded in community oncology practices to identify eligible patients for oncology clinical trials. It integrates clinical trials into routine care, activating providers, identifying eligible patients, and navigating them through the trial lifecycle across health systems, biopharma, and payers.

See all Oncology AI tools →

More from Siemens Medical Solutions USA

ACUSON Sequoia Diagnostic Ultrasound System
Siemens Medical Solutions USA
Radiology & Imaging AI
The ACUSON Sequoia Diagnostic Ultrasound System by Siemens Healthineers is a premium platform featuring BioAcoustic imaging, InFocus technology, and AI-powered tools to deliver consistent, high-resolution ultrasound imaging across diverse patient types and clinical applications.
AI Rad Companion (Engine)
Siemens Medical Solutions USA
Radiology & Imaging AI
Siemens AI-Rad Companion (Engine) is an FDA-cleared, AI-powered, cloud-based platform that streamlines radiology workflows and enhances diagnostic precision through automated image post-processing and structured reporting across multiple modalities.
AI-Rad Companion (Musculoskeletal)
Siemens Medical Solutions USA
Radiology & Imaging AI
AI-Rad Companion (Musculoskeletal) by Siemens Medical Solutions USA is an FDA-cleared AI-powered image processing software for quantitative and qualitative analysis of musculoskeletal conditions from CT DICOM images, supporting radiologists and physicians in diagnostic evaluation.
AI-Rad Companion Engine
Siemens Medical Solutions USA
Radiology & Imaging AI
The AI-Rad Companion Engine is an AI-powered, cloud-based platform by Siemens Medical Solutions USA that automates post-processing and enhances diagnostic precision in medical image interpretation across multiple modalities.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-20 | First Added: 2026-04-20
AI Tool Finder
AI-powered search. Results may not be comprehensive.